A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Study Summary

The purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma (RRMM).

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions / Drugs

mRNA-2808

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment166 participants

Primary Completion—

Lead SponsorModernaTX, Inc.

Data Retrieved2026-04-11 02:55:38.209269+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.